NewsBenzingaLeerink Partners belässt 10x Genomics auf „Market Perform“ und hebt das Kursziel auf 90 US-Dollar an Leerink Partners belässt 10x Genomics auf „Market Perform“ und hebt das Kursziel auf 90 US-Dollar an Benzinga 2026.09.29 16:28 (GMT+0) Open on Benzinga Other news Scotiabank Initiates Coverage On Pinnacle West Capital with Sector Outperform Rating, Announces Price Target of $104 Scotiabank Initiates Coverage On ONE Gas with Sector Outperform Rating, Announces Price Target of $86 Why Is Quantum-Si Stock Gaining Tuesday? Scotiabank Initiates Coverage On OGE Energy with Sector Outperform Rating, Announces Price Target of $49 What's Going On With the Drop in Alphabet Stock? Scotiabank Initiates Coverage On NiSource with Sector Perform Rating, Announces Price Target of $43
Scotiabank Initiates Coverage On Pinnacle West Capital with Sector Outperform Rating, Announces Price Target of $104
Scotiabank Initiates Coverage On ONE Gas with Sector Outperform Rating, Announces Price Target of $86
Scotiabank Initiates Coverage On OGE Energy with Sector Outperform Rating, Announces Price Target of $49
